Medicare Rx Spending Relationship To Medical Costs Explored In Dartmouth Report
This article was originally published in The Pink Sheet Daily
The first-ever report from the Dartmouth Atlas Project to focus on prescription drug use in Medicare offers a view of the difficulties involved in making assumptions regarding the cost effectiveness of drugs within the program and how their use can lower other medical costs.
You may also be interested in...
In a policy change, the Congressional Budget Office, which estimates the impact of legislation on federal spending, will account for pharmaceuticals’ effect on overall medical spending in Medicare for bills that directly affect drug use.
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’
Center for American Progress suggests pricing reforms for the 'next Administration' in lieu of legislation.